The primary objective is to clinically evaluate the efficacy of albumin versus hyaluronic acid scaffolds in combination with concentrated growth factors in the non- surgical treatment of stage II/III periodontitis. The secondary objective is to evaluate the duration and concentration of different growth factors release in the gingival crevicular fluid.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Plaque index (PI)
Timeframe: baseline, 6weeks, 12weeks
Bleeding on probing (BOP)
Timeframe: baseline, 6weeks, 12weeks
Probing pocket Depth (PPD)
Timeframe: baseline, 6weeks, 12weeks
Clinical Attachment Level (CAL)
Timeframe: baseline, 6weeks, 12weeks